Does the RYGB Common Limb Length influence Hypertension Remission, Weight Loss and Cardio-Metabolic Parameters? Data from the GATEWAY TRIAL

Background: Although Roux-en-Y Gastric Bypass (RYGB) results for weight loss (WL) and cardio-metabolic improvement are well established, there is no consensus for the optimum limb lengths to obtain the best results.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Tags: TUESDAY, NOVEMBER 13, 201810:00 am--12:00 pm Source Type: research